{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T05:07:44Z","timestamp":1781932064345,"version":"3.54.5"},"reference-count":25,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T00:00:00Z","timestamp":1177977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2007,5]]},"DOI":"10.1016\/j.diagmicrobio.2006.11.002","type":"journal-article","created":{"date-parts":[[2007,5,11]],"date-time":"2007-05-11T11:47:15Z","timestamp":1178884035000},"page":"117-120","source":"Crossref","is-referenced-by-count":20,"title":["Successful treatment of a disseminated Sporothrix schenckii infection and in vitro analysis for antifungal susceptibility testing"],"prefix":"10.1016","volume":"58","author":[{"given":"Lidiane Meire","family":"Kohler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fania Soares","family":"Hamdan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa Cristina Abreu","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diagmicrobio.2006.11.002_bib1","first-page":"1","article-title":"Sporothrix schenckii infection presented as monoarthritis: report of two cases and review of the literature","volume":"7","author":"Appenzeller","year":"2005","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.diagmicrobio.2006.11.002_bib2","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/00001432-200104000-00006","article-title":"Endemic sporotrichosis","volume":"14","author":"Bustamante","year":"2001","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2006.11.002_bib3","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1586\/14787210.2.1.85","article-title":"Sporotrichosis: a forgotten disease in the drug research agenda","volume":"2","author":"Bustamante","year":"2004","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"10.1016\/j.diagmicrobio.2006.11.002_bib4","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1139\/m97-169","article-title":"Effect of three azole derivatives on the lipids of different strains of Sporothrix schenckii","volume":"43","author":"Casali","year":"1997","journal-title":"Can. J. Microbiol."},{"key":"10.1016\/j.diagmicrobio.2006.11.002_bib5","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1046\/j.1439-0507.2003.00953.x","article-title":"Comparative evaluation of the efficacy and safety of two doses of terbinafine (500 and 1000 mg day\u22121) in the treatment of cutaneous or lymphocutaneous sporotrichosis","volume":"47","author":"Chapman","year":"2004","journal-title":"Mycoses"},{"key":"10.1016\/j.diagmicrobio.2006.11.002_bib6","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1136\/ard.50.2.112","article-title":"Sporotrichal arthritis","volume":"50","author":"Chowdhary","year":"1991","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.diagmicrobio.2006.11.002_bib7","series-title":"Reference method for broth dilution antifungal susceptibility testing of yeast. Approved Standard CLSI Document M27-A2","author":"Clinical Laboratory Standards Institute","year":"2002"},{"key":"10.1016\/j.diagmicrobio.2006.11.002_bib8","series-title":"Reference method for broth dilution antifungal susceptibility testing of filamentous fungi. Approved Standard Document M38-A","author":"Clinical Laboratory Standards Institute","year":"2002"},{"key":"10.1016\/j.diagmicrobio.2006.11.002_bib9","first-page":"214","article-title":"In vitro susceptibility pattern of Sporothrix schenckii strains isolated from three centers in India","volume":"113","author":"Ghosh","year":"2001","journal-title":"Indian J. Med. Res."},{"key":"10.1016\/j.diagmicrobio.2006.11.002_bib10","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1046\/j.1365-4362.2001.01300.x","article-title":"Disseminated cutaneous sporotrichosis: a marker of osteoarticular sporotrichosis masquerading as gout","volume":"40","author":"Gordhan","year":"2001","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.diagmicrobio.2006.11.002_bib11","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/00003086-199801000-00028","article-title":"Sporotrichal arthritis in South Central Kansas","volume":"346","author":"Howell","year":"1998","journal-title":"Clin. Orthop. Relat. Res."},{"key":"10.1016\/j.diagmicrobio.2006.11.002_bib12","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1080\/mmy.38.2.155.159","article-title":"An evaluation of the in vitro activity of terbinafine","volume":"38","author":"Jessup","year":"2000","journal-title":"Med. Mycol."},{"key":"10.1016\/j.diagmicrobio.2006.11.002_bib13","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1086\/520190","article-title":"Sporotrichosis","volume":"29","author":"Kauffman","year":"1999","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2006.11.002_bib15","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1093\/clinids\/22.1.46","article-title":"Treatment of lymphocutaneous and visceral sporotrichosis with fluconazole","volume":"22","author":"Kauffman","year":"1996","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2006.11.002_bib14","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1086\/313751","article-title":"Practice guidelines for the management of patients with sporotrichosis","volume":"30","author":"Kauffman","year":"2000","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2006.11.002_bib16","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/j.1439-0507.2001.00637.x","article-title":"Case report. Successfully treated subcutaneous infection with Sporothrix schenckii in Turkey","volume":"44","author":"Ko\u00e7","year":"2001","journal-title":"Mycoses"},{"key":"10.1016\/j.diagmicrobio.2006.11.002_bib17","doi-asserted-by":"crossref","first-page":"4319","DOI":"10.1128\/JCM.42.9.4319-4320.2004","article-title":"In vitro susceptibilities of isolates of Sporothrix schenckii to itraconazole and terbinafine","volume":"42","author":"Kohler","year":"2004","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.diagmicrobio.2006.11.002_bib18","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1139\/w06-040","article-title":"In vitro susceptibilities of isolates of Sporothrix schenckii to amphotericin B, itraconazole, and terbinafine: comparison of yeast and mycelial forms","volume":"52","author":"Kohler","year":"2006","journal-title":"Can. J. Microbiol."},{"key":"10.1016\/j.diagmicrobio.2006.11.002_bib19","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/jac\/43.3.321","article-title":"Endemic mycoses: a treatment update","volume":"43","author":"Lortholary","year":"1999","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.diagmicrobio.2006.11.002_bib20","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1128\/AAC.41.8.1832","article-title":"In vitro evaluation of voriconazole against some clinically important fungi","volume":"41","author":"McGinnis","year":"1997","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2006.11.002_bib21","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/0190-9622(93)70124-C","article-title":"Sporotrichosis presenting as arthritis and subcutaneous nodules","volume":"28","author":"Purvis","year":"1993","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.diagmicrobio.2006.11.002_bib22","series-title":"Medical Mycology: the Pathogenic Fungi and The Pathogenic Actinomycetes","first-page":"277","article-title":"Sporotrichosis","author":"Rippon","year":"1988"},{"key":"10.1016\/j.diagmicrobio.2006.11.002_bib23","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1439-0507.1999.tb00026.x","article-title":"Activity of terbinafine against serious fungal pathogens","volume":"42","author":"Ryder","year":"1999","journal-title":"Mycoses"},{"key":"10.1016\/j.diagmicrobio.2006.11.002_bib24","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1469-0691.2006.01366.x","article-title":"Infectious arthritis: clinical features, laboratory findings and treatment","volume":"12","author":"Smith","year":"2006","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.diagmicrobio.2006.11.002_bib25","doi-asserted-by":"crossref","first-page":"3952","DOI":"10.1128\/AAC.49.9.3952-3954.2005","article-title":"In vitro antifungal susceptibility of Sporothrix schenckii in two growth phases","volume":"49","author":"Trilles","year":"2005","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889306004305?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889306004305?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,27]],"date-time":"2019-04-27T21:28:45Z","timestamp":1556400525000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889306004305"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,5]]}},"alternative-id":["S0732889306004305"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2006.11.002","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2007,5]]}}}